(Q74617178)
Statements
A comparative study of 500 mg BID and 250 mg BID of prophylactic oral ganciclovir in post-kidney transplant "CMV at risk" recipients (English)
H C Yang
M J Holman
E Langhoff
C A Dellock
M Gupta
P J Ulsh
1 February 1999